Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats

Hepatology

Volumn 33, Issue 2, 2001, Pages 379-386

  Bruck, Rafael ^a   Genina, Olga ^b   Aeed, Hussein ^a   Alexiev, Rosaly ^b   Nagler, Arnon ^c   Avni, Yona ^a   Pines, Mark ^b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b VOLCANI CENTER   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COLLAGEN TYPE 1; HALOFUGINONE; SCLEROPROTEIN; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT; STELLATE CELL;

EID: 0035142629     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.21408     Document Type: Article

References (59)

1. Liver fibrosis
2. Gene therapy for liver fibrosis
3. In vivo inhibition of rat stellate cells activation by soluble transforming growth factor beta type II receptor: A potential new therapy for hepatic fibrosis
4. The cellular basis of hepatic fibrosis. Mechanism and treatment strategies
5. Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
6. The hepatic stellate (Ito) cell: Its role in human liver disease
7. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: A key event in hepatic fibrogenesis
8. Pathogenesis of liver fibrosis
9. Collagen of normal and cirrhotic human liver
10. Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins
11. Type I collagen gene regulation and molecular pathogenesis of cirrhosis
12. 4-induced hepatic fibrosis
13. Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: A link to tissue fibrosis?
14. Albumin and collagen gene regulation in alcohol- and virus-induced human liver disease
15. Gene expression of type I, III, and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat
16. Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen
17. Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: Regulation by cytokines
18. Cellular and molecular aspects of hepatic fibrosis
19. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis
20. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis
21. Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat
22. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment
23. Transforming growth factor β and α in chronic liver disease - Effects of interferon therapy
24. Perspectives in the treatment of liver fibrosis
25. Halofuginone - A novel anti-fibrotic therapy
26. Halofuginone: An inhibitor of collagen type I synthesis
27. Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intima hyperplasia
28. Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: Effect of halofuginone
29. Inhibition of collagen synthesis and changes in skin morphology in murine graft versus host disease and tight skin mice: Effect of halofuginone
30. Reduction in pulmonary fibrosis in vivo by halofuginone
31. Topically applied halofuginone, an inhibitor of collagen type I transcription, reduced peritendinous fibrous adhesions following surgery
32. Halofuginone - An inhibitor of collagen type I synthesis - Prevents post-operation abdominal adhesions formation
33. Halofuginone - An inhibitor of collagen type I synthesis - Prevents formation of post-operative adhesions in the rat uterine horn model
34. Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis
35. Topical treatment of cutaneous chronic graft versus host disease (cGvHD) with halofuginone: A novel inhibitor of collagen type I synthesis
36. Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-GlyAsp epitope
37. Thioacetamide-induced cirrhosis-like lesions in rats - Usefulness and reliability of this animal model
38. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration
39. Chromatography of amino acid on sulfonated polysterene resin
40. Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats
41. Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells
42. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis
43. Synthesis and degradation of type I procollagen mRNAs in cultured human skin fibroblasts and the effect of cortisol
44. Transcriptional and posttranscriptional effects of dexamethasone on albumin and procollagen messenger RNAs in routine schistosomiasis
45. Increased skin tearing in broilers and reduced collagen synthesis in skin in vivo and in vitro in response to the coccidiostat halofuginone
46. Inhibition of neovascularization, tumor growth and facilitation of wound repair by halofuginone, an inhibitor of collagen type I synthesis
47. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression
48. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix
49. Molecular mechanisms in the reversible regulation of morphology, proliferation and collagen metabolism in hepatic stellate cells by the three-dimensional structure of the extracellular matrix
50. Activation of cultured rat hepatic stellate cells by tumoral hepatocytes
51. Hepatocyte-matrix interactions
52. Effect of pentoxifylline on the degradation of procollagen type I by human hepatic stellate cells in response to transforming growth factor β1
53. Two different cis-acting regulatory regions direct cell-specific transcription of the collagen alpha 1(I) gene in hepatic stellate cells and in skin and tendon fibroblasts
54. Suppression of stellate cell type I collagen gene expression involves AP-2 transmodulation of nuclear factor-1-dependent gene transcription
55. Structure and characterization of the human tissue inhibitor of metalloproteinase-2 gene
56. Localization and semiquantitative assessment of hepatic procollagen mRNA in primary biliary cirrhosis
57. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
58. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat
59. Reversibility of cholestatic changes following experimental common bile duct obstruction: Fact or fantasy?